Loading the map…
Private limited company registered in Grays, classed under “Other education n.e.c.”.
Headline figures
FY to Aug 2025 · Company only
Turnover
For subscribers
Profit after tax
—
Not filed: small-company exemption
Net assets
For subscribers
Cash
For subscribers
Employees
For subscribers
What the numbers say
2 findings from the figures, in plain English
Written by rules from the figures on this page. Not a forecast or a credit opinion.
History
| £ | 2024 | 2025 |
|---|---|---|
| Profit after tax | — | |
| Turnover | ||
| Net assets | ||
| Cash | ||
| Employees |
Every figure for all 2 years
“—” means we did not find the figure in a source; it is never filled with an estimate.
Balance sheet and ratios
From the filed balance sheets · £
| Balance sheet | 2024 | 2025 |
|---|---|---|
| Current assets | ||
| Creditors due within a year | ||
| Net current assets | ||
| Net assets | ||
| Ratios | ||
| Current ratioCurrent assets for every £1 owed within a year | ||
| Creditors to assetsEverything owed to creditors as a share of fixed plus current assets | ||
4 balance-sheet lines and 2 ratios, every year
A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.
Questions people ask
›What does Medipath International do?
Private limited company registered in Grays, classed under “Other education n.e.c.”.
›How much turnover does Medipath International make?
Answered in the full report
›Is Medipath International profitable?
Medipath International's profit isn't public: small companies may file without a profit and loss account.
›How many people work at Medipath International?
Answered in the full report
›Where is Medipath International based?
Its registered office is 6 Mayflower Road, Chafford Hundred, Grays, RM16 6BE, in Grays.
›When was Medipath International founded?
Medipath International Limited was incorporated on 13 August 2023.
›Is Medipath International still trading?
The register lists Medipath International Limited as active.